VB
Valion Bio, Inc.
VBIO · NASDAQ
$2.49 +2.68% (+$0.07)
1M -40.00%
Piotroski F-Score Weak
2/9Valuation
-
N/A P/B N/A
P/FFO N/A
P/E N/A
Growth
-
N/A Book val. growth N/A
FCF growth N/A
EPS growth N/A
Profitability
-
N/A FCF margin N/A
Op. margin N/A
Gross margin N/A
Quality
-
N/A Asset turnover N/A
ROA N/A
ROIC N/A
Debt
-
N/A Net debt/EBITDA N/A
Int. coverage N/A
Debt/Equity N/A
Stability
9 /100
Unstable Beta 1.79x
EPS volatility N/A
Profitable years N/A
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na VBIO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Michael R. Cavanaugh
Employees
52
Headquarters
San Antonio
Nadcházející události
13 LIS
Earnings
Upcoming earnings report